Reclassification of serous ovarian carcinoma by a 2-tier system: a Gynecologic Oncology Group Study.
about
Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)Targeting TBP-Associated Factors in Ovarian CancerNutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian CarcinomasThe prognostic significance of pre- and post-treatment CA-125 in grade 1 serous ovarian carcinoma: a gynecologic Oncology Group study.TGF-beta induces serous borderline ovarian tumor cell invasion by activating EMT but triggers apoptosis in low-grade serous ovarian carcinoma cells.A survival analysis comparing women with ovarian low-grade serous carcinoma to those with high-grade histologySurvival in women with grade 1 serous ovarian carcinomaIntratumoral heterogeneity in a minority of ovarian low-grade serous carcinomasBevacizumab shows activity in patients with low-grade serous ovarian and primary peritoneal cancerImpact of Age and Primary Disease Site on Outcome in Women With Low-Grade Serous Carcinoma of the Ovary or Peritoneum: Results of a Large Single-Institution Registry of a Rare Tumor.A binary histologic grading system for ovarian serous carcinoma is an independent prognostic factor: a population-based study of 4317 women diagnosed in Denmark 1978-2006Extreme Outlier Analysis Identifies Occult Mitogen-Activated Protein Kinase Pathway Mutations in Patients With Low-Grade Serous Ovarian Cancer.MET/HGF Signaling Pathway in Ovarian Carcinoma: Clinical Implications and Future Direction.Significance of lymphovascular space invasion in epithelial ovarian cancer.Specificity and prognostic validation of a polyclonal antibody to detect Six1 homeoprotein in ovarian cancerTubal ligation and ovarian cancer risk in a large cohort: Substantial variation by histological typeEpigenetic analysis of the Notch superfamily in high-grade serous ovarian cancerEpithelial ovarian cancer: the molecular genetics of epithelial ovarian cancerMarkers of fibroblast-rich tumor stroma and perivascular cells in serous ovarian cancer: Inter- and intra-patient heterogeneity and impact on survivalCytologic changes of ovarian epithelial cancer induced by neoadjuvant chemotherapyOvarian cancer: genomic analysis.Clinical implications of using molecular diagnostics for ovarian cancers.EphA5 protein, a potential marker for distinguishing histological grade and prognosis in ovarian serous carcinoma.BRAF mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer.Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma.Low-grade serous carcinoma: molecular features and contemporary treatment strategies.Incidence of lymph node metastases in clinical early-stage mucinous and seromucinous ovarian carcinoma: a retrospective cohort study.Validation of a two-tier grading system in an unselected, consecutive cohort of serous ovarian cancer patients.Brain metastasis in advanced serous borderline tumor of the ovary: A case presentationCancer of the ovary, fallopian tube, and peritoneum.Prognostic role of E-cadherin in patients with advanced serous ovarian cancer.Trends of low-grade serous ovarian carcinoma in the United States.KRAS mutation testing in borderline ovarian tumors and low-grade ovarian carcinomas with a rapid, fully integrated molecular diagnostic system.Determination of BRAF V600E (VE1) protein expression and BRAF gene mutation status in codon 600 in borderline and low-grade ovarian cancers.Nomograms Predicting Platinum Sensitivity, Progression-Free Survival, and Overall Survival Using Pretreatment Complete Blood Cell Counts in Epithelial Ovarian Cancer.Low-grade serous carcinoma of the ovary or peritoneum.[Grading of gynecological tumors : Current aspects].WT1, p53 and p16 expression in the diagnosis of low- and high-grade serous ovarian carcinomas and their relation to prognosis.Transcriptomic and genomic profiling of early-stage ovarian carcinomas associated with histotype and overall survival
P2860
Q26852127-51EBB3E6-3B9A-4DB1-86BA-0660DDE80479Q26866045-4430F899-C432-461E-992C-ADD3053F4C53Q28547093-95923AFB-625B-485C-8034-8D336985ADECQ30405874-BA890C18-19E3-4699-B226-72F2F668193FQ34384395-A0CA3215-D8FA-421F-A151-CD0952617EB1Q34387999-18B25522-1CB4-4B39-B195-C9D9137A0FE3Q34967339-17434D3F-7173-4080-8A17-CA00BCA5ED1EQ35060446-C2746A17-F443-4B0C-BE1F-9B632BB94ABEQ35461505-377DAFF0-A838-439F-B6F4-D60F08506BA2Q35947034-D04AD7ED-0BDC-4CC3-9DA6-A93E9A4180E9Q35980522-E02FC5B1-48A0-44A2-80CA-967C8E569A4BQ36346641-A0DFC35C-BBAF-4A63-ACAD-2032D5659033Q36520263-2838B065-E68A-4BAD-8468-EBACADB17998Q36530725-A8DD32EC-073C-4F5D-87E2-EDAC80D1E0FEQ36714078-833F5A41-ABB3-4462-91F6-8B69B509A71BQ36799895-96AD11CA-446C-4F8F-8D36-43F587AA4318Q36819232-D460C446-D5CE-4C86-9C63-BE61BB03BFA1Q36855239-8827F1A8-93D5-45A5-88E8-010A7BDA7AF0Q37109818-E2334F6B-BB73-4158-B1B2-CEFFE7CE84D2Q37228849-E24CF1D1-E0AF-4837-98A3-A386E6EB9832Q37332480-CBBA30B5-D1C0-4380-8254-55C8DBDE57C0Q37332490-21420286-B92D-4E0D-AE57-7AFA4AF27208Q37440072-1EE7A39B-5BA2-4D03-829E-630F74EF5BECQ37652173-6D40D50E-70A3-4DB6-BA3A-27302C776896Q38372474-9BF27634-11B8-4F5E-A6B2-6497CC11A312Q38514737-428F9C2B-055C-4129-9087-FA526C936138Q39176734-CDCCAB12-1ACA-4423-8017-D29ACD8A551DQ40844578-DCF3610C-B19C-4EC1-9DDA-F38E065E4842Q41179937-1890EB03-59A6-49EA-AD75-7ED4047112B9Q41266914-A266E71C-49EB-4CAB-8DBE-D03C6D919902Q44370636-DFBF937A-4E15-4822-849F-AF5AAE055985Q46431112-1B79676E-DF8F-4DB3-842B-991C9AFD1E85Q47248242-9FEB8104-2CEE-422C-8967-9163D96800BEQ47376223-AA133AAF-E6C4-4CCA-B4C6-AC3F2D50CD1EQ49674385-067CA61A-1DC6-4DD0-A37A-EA15FE5E0A28Q50856533-653C9B4E-9527-4E11-AA57-BEA15F539AB2Q52861155-37F65A3A-1820-43B5-A154-24B31DE26B6DQ55214019-0932A40C-FCF1-42D6-8DAE-18013736819FQ58738631-AB600F26-4538-4F33-B1E2-4997F6A1E9D9
P2860
Reclassification of serous ovarian carcinoma by a 2-tier system: a Gynecologic Oncology Group Study.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Reclassification of serous ova ...... ecologic Oncology Group Study.
@en
Reclassification of serous ova ...... ecologic Oncology Group Study.
@nl
type
label
Reclassification of serous ova ...... ecologic Oncology Group Study.
@en
Reclassification of serous ova ...... ecologic Oncology Group Study.
@nl
prefLabel
Reclassification of serous ova ...... ecologic Oncology Group Study.
@en
Reclassification of serous ova ...... ecologic Oncology Group Study.
@nl
P2093
P2860
P356
P1433
P1476
Reclassification of serous ova ...... ecologic Oncology Group Study.
@en
P2093
Anil K Sood
Behnaz Behmaram
Charlotte C Sun
Chunqiao Tian
David M Gershenson
Diane C Bodurka
Golnar Rasty
Karen H Lu
Margaret Steinhoff
Michael J Birrer
P2860
P304
P356
10.1002/CNCR.26618
P407
P577
2011-11-09T00:00:00Z